New Options in High-Risk Early Breast Cancer

Slideset: 100

Share

Program Content

Activities

  • High-Risk EBC
    New Options in High-Risk Early Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 27, 2023

  • Targeted Therapy in EBC
    My Experience Managing Key Adverse Events With Oral Targeted Therapy for High-Risk Early Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2023

  • PCE oncology fall 2023 BC
    New Options in High-Risk Early Breast Cancer
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 11, 2023

    Expires: December 10, 2024

Faculty

cover img faculity

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

cover img faculity

Kathleen Madden, FNP, MSN, AOCNP, APHN

Melanoma Program
NYU Langone Perlmutter Cancer Center
New York, NY

Provided by

ProCE Banner

Supporters

Supported by educational grants from Merck Sharp & Dohme, LLC and AstraZeneca.

AstraZeneca

Merck Sharp & Dohme, LLC